Physician profile
Marisa Messore
NPI 1942389804
$1,805.45
in general payments reported to CMS, 2019-2025
17 companies · $260 in 2025
The $260 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $615 · 2020: $144 · 2021: $304 · 2022: $106 · 2023: $85.68 · 2024: $291 · 2025: $260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $523 · Education: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $523.06 |
| Education | $113.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $416.46 | 2019-2021 | |
| Astellas Pharma US INC | $339.34 | 2023-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $229.27 | 2019-2025 | Thinprep 2000 Processor, Aptima |
| Mayne Pharma Commercial LLC | $207.71 | 2021-2025 | |
| Therapeuticsmd, INC. | $192.01 | 2019-2022 | |
| Millicent US INC | $74.44 | 2020-2025 | Intrarosa, Femring |
| Allergan, INC. | $61.66 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $58.97 | 2019 | |
| Pfizer INC. | $46.92 | 2022-2024 | |
| Agile Therapeutics, INC. | $45.39 | 2021-2024 | Twirla |
| Evofem Biosciences, INC. | $37.23 | 2021-2024 | |
| Scynexis, INC. | $20.59 | 2022 | |
| Coopersurgical, INC. | $15.88 | 2019 | |
| Exeltis, USA INC. | $15.73 | 2022 | |
| Dysis Medical, INC. | $15.14 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $14.63 | 2020 | |
| Ascend Therapeutics US, LLC | $14.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marisa Messore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.